Bristol Myers Squibb (BMY) Assets Average (2009 - 2026)

Bristol Myers Squibb (BMY) has 17 years of Assets Average data on file, last reported at $88.3 billion in Q1 2026.

• Assets Average for Q1 2026 came in at $88.3 billion, down 4.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $88.3 billion (down 4.6% YoY), and the FY2025 annual result was $91.3 billion, down 2.73% from the prior year.
• Assets Average declined to $88.3 billion in Q1 2026 per BMY's latest filing, from $93.5 billion in the prior quarter.
• Over five years, Assets Average peaked at $106.2 billion in Q1 2022 and troughed at $88.3 billion in Q1 2026.
• A 5-year average of $95.6 billion and a median of $94.2 billion in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average decreased 11.44% in 2022, then climbed 3.15% in 2024.
• A 5-year view of Assets Average shows it stood at $97.5 billion in 2022, then retreated by 4.41% to $93.2 billion in 2023, then fell by 0.08% to $93.1 billion in 2024, then grew by 0.35% to $93.5 billion in 2025, then decreased by 5.57% to $88.3 billion in 2026.
• Business Quant data shows BMY's Assets Average at $88.3 billion in Q1 2026, $93.5 billion in Q4 2025, and $95.8 billion in Q3 2025.